More Mayne Pharma Group Ltd. news
Mayne Pharma Group Ltd.ASX: MYX

Outcome of litigation and update on Scheme

Oct 15, 2025 at 10:46 PM EDT · Issued by Mayne Pharma Group Ltd.

Filed with ASX · Oct 15, 2025 at 10:46 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/outcome-of-litigation-and-update-on-scheme

Watch Mayne Pharma's latest call↗Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call↗

Mayne Pharma Group Ltd. on 6ix

Story so far

  • Results of Scheme MeetingJun 18, 2025
  • Chair's address and presentation at the Scheme MeetingJun 18, 2025
  • Supplementary Scheme BookletJun 5, 2025

Earlier from Mayne Pharma

  • MYX announces PBS listing of NEXTSTELLIS in AustraliaSep 29, 2025
  • Mayne Pharma addresses recent media articles regarding FIRBSep 7, 2025
  • 2025 Full Year Results Investor PresentationAug 28, 2025
  • 2025 Full Year Results Media ReleaseAug 28, 2025
  • Full Year Statutory AccountsAug 28, 2025

Later from Mayne Pharma

  • MYX Scheme of Arrangement update on FIRB approvalOct 30, 2025
  • Update on Scheme and Supreme Court of NSW proceedingsNov 10, 2025
  • MYX - Panel Conducts Proceedings and Makes Interim OrdersNov 14, 2025
  • Update on FIRB approval and SchemeNov 17, 2025
  • MYX Declaration of Unacceptable Circumstances and OrdersNov 19, 2025
All Mayne Pharma news releases↗

Follow Mayne Pharma into a list and get an email when it puts out news.

Follow Mayne Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer